Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2022 · fourth_quarter · Health Issues
H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Provisions relating to NIH, Substance Use Research Barriers to research resulting from DEA scheduling, Drug research related issues Public Law 117-215, Cannabidiol & Marijuana Research Expansion Act, Drug use research related issues H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act H.R.2405, Streamlining Research on Controlled Substances Act H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act S.4591, Cannabis Administration and Opportunity Act, Drug use research H.R.6184/S.3336, HALT Fentanyl Act, Drug use research related issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Provisions related to NIH and Substance use research Monitor H.R.6946, SAFE Act of 2022, Drug use research related issues
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2022 · third_quarter · Health Issues
H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Provisions relating to NIH, Substance Use Research H.R.2630, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act Barriers to research resulting from DEA scheduling, Drug research related issues H.R.8454/S.253, Cannabidiol & Marijuana Research Expansion Act, Drug use research related issues H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act H.R.2405, Streamlining Research on Controlled Substances Act H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act S.4591, Cannabis Administration and Opportunity Act, Drug use research H.R.6184/S.3336, HALT Fentanyl Act, Drug use research related issues H.R.6946, SAFE Act of 2022, Drug use research related issues Monitor Public Law 117-70, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act, Drug use research related issues
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2022 · second_quarter · Law Enforcement/Crime/Criminal Justice
S.426 - Inspector General Access Act of 2021, fentanyl & fentanyl analogue temporary scheduling, H.R. 6184, S. 3336 HALT Fentanyl Act; COVID-19 and criminal justice issues including compassionate release; cocaine sentencing issues; H.R. 7300 Dark Web Interdiction Act of 2022; HALT Fentanyl Act H.R. 6184; Comments for the Record for Oversight Hearing on Clemency and the Office of the Pardon Attorney
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Provisions relating to NIH, Substance Use Research Barriers to research resulting from DEA scheduling, Drug research related issues S.253, Cannabidiol & Marijuana Research Expansion Act, Drug use research related issues H.R.5657, Medical Marijuana Research Act, Drug use research related issues H.R.869/S.289, Research Investment to Spark the Economy Act of 2021 (RISE ACT), Drug use research related issues H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act H.R.2405, Streamlining Research on Controlled Substances Act H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act S.1006, Amend Controlled Substances Act to list fentanyl-related substances to Schedule I controlled substances Public Law 117-70, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act, Drug use research related issues Cannabis Administration and Opportunity Act, Drug use research H.R.6184/S.3336, HALT Fentanyl Act, Drug use research related issues H.R.6946, SAFE Act of 2022, Drug use research related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2022 · first_quarter · Law Enforcement/Crime/Criminal Justice
S.426 - Inspector General Access Act of 2021, fentanyl & fentanyl analogue temporary scheduling, H.R. 6184, S. 3336 HALT Fentanyl Act; COVID-19 and criminal justice issues including compassionate release; cocaine sentencing issues; H.R. 7300 Dark Web Interdiction Act of 2022;
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Provisions relating to NIH, substance use research Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023 Public Law 117-103, Consolidated Appropriations Act, FY2022 Public Law 117-86, Further Additional Extending Government Funding Act Barriers to research resulting from DEA scheduling, Drug research related issues S.253, Cannabidiol & Marijuana Research Expansion Act, Drug use research related issues H.R.5657, Medical Marijuana Research Act, Drug use research related issues H.R.869/S.289, Research Investment to Spark the Economy Act of 2021 (RISE ACT), Drug use research related issues H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act H.R.2405, Streamlining Research on Controlled Substances Act H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act S.1006, Amend Controlled Substances Act to list fentanyl-related substances to Schedule I controlled substances Public Law 117-70, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act, Drug use research related issues Cannabis Administration and Opportunity Act, Drug use research H.R.6184/S.3336, HALT Fentanyl Act, Drug use research related issues
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2021 · fourth_quarter · Health Issues
H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Provisions relating to NIH, substance use research Barriers to research resulting from DEA scheduling, Drug research related issues S.253, Cannabidiol & Marijuana Research Expansion Act, Drug use research related issues Medical Marijuana Research Act, Drug use research related issues H.R.869/S.289, Research Investment to Spark the Economy Act of 2021 (RISE ACT), Drug use research related issues H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act H.R.2405, Streamlining Research on Controlled Substances Act H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act S.1006, Amend Controlled Substances Act to list fentanyl-related substances to Schedule I controlled substances Public Law 117-70, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act, Drug use research related issues Cannabis Administration and Opportunity Act, Drug use research H.R.6184, HALT Fentanyl Act, Drug use research related issues S.3336, HALT Fentanyl Act, Drug use research related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE